References

1. Takeichi, M. Morphogenetic roles of classic Cadherins. Curr. Opin. Cell Biol. 1995, 7 (5), 619-627.

2. Grunwald, G.B. The structural and functional analysis of

Cadherin calcium-dependent cell adhesion molecules. Curr. Opin. Cell Biol. 1993, 5 (5), 797-805.

3. Becker, K.F.; Hofler, H. Frequent somatic allelic inactiva-tion of the E-cadherin gene in gastric carcinomas. J. Natl. Cancer Inst. 1995, 87 (14), 1082-1084.

4. Machado, J.C.; Soares, P.; Carneiro, F.; Rocha, A.; Beck, S.; Blin, N.; Berx, G.; Sobrinho-Simoes, M. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Lab. Invest. 1999, 79 (4), 459 -465.

5. Becker, K.F.; Atkinson, M.J.; Reich, U.; Becker, I.; Nekarda, H.; Siewert, J.R.; Hofler, H. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 1994, 54 (14), 3845-3852.

6. Berx, G.; Becker, K.F.; Hofler, H.; van Roy, F. Mutations of the human E-cadherin (CDH1) gene. Human Mutat.

7. Guilford, P.; Hopkins, J.; Harraway, J.; McLeod, M.; McLeod, N.; Harawira, P.; Taite, H.; Scoular, R.; Miller, A.; Reeve, A.E. E-cadherin germline mutations in familial gastric cancer. Nature 1998, 392 (6674), 402-405.

8. Guilford, P.J.; Hopkins, J.B.; Grady, W.M.; Markowitz, S.D.; Willis, J.; Lynch, H.; Rajput, A.; Wiesner, G.L.; Lindor, N.M.; Burgart, L.J.; Toro, T.T.; Lee, D.; Limacher, J.M.; Shaw, D.W.; Findlay, M.P.; Reeve, A.E. E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Human Mutat. 1999, 14 (3), 249-255.

9. Richards, F.M.; McKee, S.A.; Rajpar, M.H.; Cole, T.R.; Evans, D.G.; Jankowski, J.A.; McKeown, C.; Sanders, D.S.; Maher, E.R. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum. Mol. Genet. 1999, 8 (4), 607-610.

10. Keller, G.; Vogelsang, H.; Becker, I.; Hutter, J.; Ott, K.; Candidus, S.; Grundei, T.; Becker, K.F.; Mueller, J.; Siewert, J.R.; Hofler, H. Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am. J. Pathol. 1999,155 (2), 337-342.

11. Gayther, S.A.; Gorringe, K.L.; Ramus, S.J.; Huntsman, D.; Roviello, F.; Grehan, N.; Machado, J.C.; Pinto, E.; Seruca, R.; Halling, K.; McLeod, P.; Powell, S.M.; Jackson, C.E.; Ponder, B.A.; Caldas, C. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res. 1998, 58 (18), 4086-4089.

12. Yoon, K.A.; Ku, J.L.; Yang, H.K.; Kim, W.H.; Park, S.Y.; Park, J.G. Germline mutations of E-cadherin gene in Korean familial gastric cancer patients. J. Hum. Genet.

13. Shinmura, K.; Kohno, T.; Takahashi, M.; Sasaki, A.; Ochiai, A.; Guilford, P.; Hunter, A.; Reeve, A.E.; Sugimura, H.; Yamaguchi, N.; Yokota, J. Familial gastric cancer: Clinicopathological characteristics, RER pheno-type and germline p53 and E-cadherin mutations. Carcinogenesis 1999, 20 (6), 1127-1131.

14. Caldas, C.; Carneiro, F.; Lynch, H.T.; Yokota, J.; Wiesner, G.L.; Powell, S.M.; Lewis, F.R.; Huntsman, D.G.; Pharoah, P.D.; Jankowski, J.A.; MacLeod, P.; Vogelsang,

H.; Keller, G.; Park, K.G.; Richards, F.M.; Maher, E.R.; Gayther, S.A.; Oliveira, C.; Grehan, N.; Wight, D.; Seruca, R.; Roviello, F.; Ponder, B.A.; Jackson, C.E. Familial gastric cancer: Overview and guidelines for management. J. Med. Genet. 1999, 36 (12), 873-880.

15. Pharoah, P.D.; Guilford, P.; Caldas, C. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 2001, 121 (6), 1348-1353.

16. Grady, W.M.; Willis, J.; Guilford, P.J.; Dunbier, A.K.; Toro, T.T.; Lynch, H.; Wiesner, G.; Ferguson, K.; Eng, C.; Park, J.G.; Kim, S.J.; Markowitz, S. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat. Genet. 2000, 26 (1), 16-17.

17. Zheng, Z.H.; Sun, X.J.; Ma, M.C.; Hao, D.M.; Liu, Y.H.; Sun, K.L. Studies of promoter methylation status and protein expression of E-cadherin gene in associated progression stages of gastric cancer. Yi Chuan Xue Bao 2003, 30 (2), 103-108.

18. Chan, A.O.; Lam, S.K.; Wong, B.C.; Wong, W.M.; Yuen, M.F.; Yeung, Y.H.; Hui, W.M.; Rashid, A.; Kwong, Y.L. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 2003, 52 (4), 502-506.

19. Malfertheiner, P.; Megraud, F.; O'Morain, C.; Hungin,

A.P.; Jones, R.; Axon, A.; Graham, D.Y.; Tytgat, G.; European Helicobacter Pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection—The Maastricht 2-2000 Consensus Report. Aliment. Pharmacol. Ther. 2002, 16 (2), 167-180.

20. Huang, J.Q.; Sridhar, S.; Chen, Y.; Hunt, R.H. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998, 114 (6), 1169-1179.

21. Brenner, H.; Bode, G.; Boeing, H. Helicobacter pylori infection among offspring of patients with stomach cancer. Gastroenterology 2000, 118 (1), 31-35.

22. Rocco, A.; Staibano, S.; Ottini, L.; Mezza, E.; Somma, P.; Mariani-Costantini, R.; Budillon, G; Nardone, G. Is there a link between environmental factors and a genetic predisposition to cancer? A lesson from a familial cluster of gastric cancers. Eur. J. Cancer 2003, 39 (11), 16191624.

23. Correa, P.; Fontham, E.T.; Bravo, J.C.; Bravo, L.E.; Ruiz,

B.; Zarama, G.; Realpe, J.L.; Malcom, G.T.; Li, D.; Johnson, W.D.; Mera, R. Chemoprevention of gastric dysplasia: Randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J. Natl. Cancer Inst. 2000, 92 (23), 1881-1888.

24. Chun, Y.S.; Lindor, N.M.; Smyrk, T.C.; Petersen, B.T.; Burgart, L.J.; Guilford, P.J.; Donohue, J.H. Germline E-cadherin gene mutations: Is prophylactic total gastrectomy indicated? Cancer 2001, 92 (1), 181-187.

25. Huntsman, D.; Carneiro, F.; Lewis, F.R.; MacLeod, P.M.; Hayashi, A.; Monaghan, K.G.; Maung, R.; Seruca, R.; Jackson, C.E.; Caldas, C. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N. Engl. J. Med. 2001, 344 (25), 1904-1909.

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment